Skip to main content
logo
Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
23.70
-0.60 (-2.47%)
At close: Sep 3, 2026, 4:00 PM EDT
23.69
-0.01 (-0.04%)
After-hours: Sep 3, 2026, 7:30 PM EDT

Collegium Pharmaceutical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
47.9262.8769.1948.16-2571.52
Depreciation & Amortization
233.6226.07169.16149.26134.1568.92
Other Amortization
4.525.346.028.648.293.41
Asset Writedown & Restructuring Costs
----4.79-
Loss (Gain) From Sale of Investments
-0.71-1.07-2.03-1.24--
Stock-Based Compensation
44.9341.9132.427.1422.8724.26
Other Operating Activities
-15.42-9.56-14.7821.07-8.15-78.02
Change in Accounts Receivable
-13.6117.2-4.413.59-21.78-22.52
Change in Inventory
-5.19-5.3513.9314.1748.27-2.3
Change in Accounts Payable
-3.756.72-11.285.06-0.71-5.83
Change in Unearned Revenue
-0.56-0.22----
Change in Other Net Operating Assets
38.18-14.59-53.21-1.09-38.544.13
Operating Cash Flow
329.92329.32204.98274.75124.23103.56
Operating Cash Flow Growth
62.14%60.66%-25.39%121.16%19.96%10.23%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.64-1.74-1.65-0.46-1.62-1.94
Cash Acquisitions
-655.4--267.54--572.07-
Investment in Securities
105.15-61.79-18.57-70.35--
Investing Cash Flow
-551.9-63.53-287.76-70.81-573.69-1.94

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-565.18325241.5517.68-
Long-Term Debt Repaid
--635.56-305.66-301.14-75-50
Net Debt Issued (Repaid)
246.91-70.3819.34-59.64442.68-50
Issuance of Common Stock
5.15.6411.079.112.1512.71
Repurchase of Common Stock
-17.9-37.95-79.2-83.36-18.11-52.01
Other Financing Activities
--7.56-11.83-6.28--
Financing Cash Flow
234.11-110.25-60.6-140.18436.72-89.3

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
12.13155.55-143.3863.76-12.7412.31

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
328.28327.58203.33274.29122.61101.61
Free Cash Flow Growth
62.67%61.11%-25.87%123.71%20.66%14.95%
Free Cash Flow Margin
40.62%41.97%32.20%48.39%26.43%36.70%
Free Cash Flow Per Share
9.078.255.036.563.622.48
Levered Free Cash Flow
324.04321.54362.08264.8770.53109.21
Unlevered Free Cash Flow
367.29367.65402.3308.32101.75118.93

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
67.6568.7662.4373.2652.5317.61
Cash Income Tax Paid
65.2460.0452.0924.2110.43.01
Change in Working Capital
15.083.76-54.9821.73-12.7113.49
SEC Filings: 10-K · 10-Q